Report of Foreign Issuer (6-k)
11 January 2020 - 12:39AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2020 (No. 5)
Commission File Number 001-37846
CELLECT BIOTECHNOLOGY LTD.
(Translation of registrant’s name into
English)
23 Hata’as
Street
Kfar Saba, Israel
44425
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
EXPLANATORY NOTE
On January 9, 2020, Mr.
Kasbian Nuriel Chirich, Cellect Biotechnology Ltd.’s (the “Company”) chairman of the board of directors
notified the Company that he resign from his position as the Company’s chairman of the board as well as director, effective
immediately. The Company thanks Mr. Chirich for his service with the Company.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
CELLECT BIOTECHNOLOGY LTD.
|
|
|
|
Date: January 10, 2020
|
By:
|
/s/ Eyal Leibovitz
|
|
|
Eyal Leibovitz
|
|
|
Chief Financial Officer
|